Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran
Open Access
- 1 March 2014
- journal article
- research article
- Published by Medknow in Asian Pacific Journal of Tropical Medicine
- Vol. 7 (3) , 193-196
Abstract
To determine the patterns of resistance to first line anti-tuberculosis (TB) drugs among a collection of Mycobacterium tuberculosis (MTB) isolates from 5 provinces of Iran. A total of the 6 426 clinical specimens from patients suspected of active TB were collected from March 2010 to June 2012. All specimens were subjected for microscopy and culture tests in the TB centers of studies provinces. Drug susceptibility testing to the first line anti-TB drugs for culture positive MTB was performed on Löwenstein-Jensen (LJ) medium using proportion method. Of 6 426 clinical specimens, 261 were culture positive for mycobacteria, of which 252 were MTB and 9 were MOTT (mycobacteria other than tuberculosis). Of 252 MTB isolates, 211 (83.7%) were pan-susceptible and 41 (16.3%) were resistant to at least one drug. Resistance was most common to streptomycin, 30 isolates (12.0%), followed by isoniazid, 20 isolates (8.0%), rifampin, 15 isolates (6.0%) and ethambutol, 14 isolates (5.5%). Sixteen (6.3%) MTB isolates were MDR. A clear evidence of heterogeneity amongst the 5 provinces in the proportions with resistance to one or more drugs was observed [χ(2); = 12.209 (4 degrees of freedom), P values = 0.015 9]. The prevalence of drug resistance in this study area underscoring the need for further enforcement of TB control strategies in the Iran. Drug susceptibility testing for all TB cases to provide optimal treatment, establishing advanced diagnostic facilities for rapid detection of MDR-TB and continuous monitoring of drug resistance are recommended for prevention and control of drug-resistant TB.Keywords
This publication has 12 references indexed in Scilit:
- Cytochrome CYP141: A new target for direct detection of Mycobacterium tuberculosis from clinical specimensActa Microbiologica Et Immunologica Hungarica, 2011
- Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysisThe Journal of Infection in Developing Countries, 2011
- First insight into the drug resistance pattern of Mycobacterium tuberculosis in Dohuk, Iraq: Using spoligotyping and MIRU-VNTR to characterize multidrug resistant strainsJournal of Infection and Public Health, 2011
- Malaria exacerbates experimental mycobacterial infection in vitro and in vivoMicrobes and Infection, 2010
- First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran—eight years of surveillanceInternational Journal of Infectious Diseases, 2009
- Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysisThe Lancet, 2006
- Comparison between Molecular Epidemiology, Geographical Regions and Drug Resistance in Mycobacterium tuberculosis Strains Isolated from Iranian and Afghan PatientsChemotherapy, 2006
- SEASONAL VARIATION IN THE RISK AND CAUSES OF MATERNAL DEATH IN THE GAMBIA: MALARIA APPEARS TO BE AN IMPORTANT FACTORThe American Journal of Tropical Medicine and Hygiene, 2004
- The Global Problem of Multidrug-Resistant TuberculosisJAMA, 2000
- A NEW AND RAPID METHOD FOR THE ISOLATION AND CULTIVATION OF TUBERCLE BACILLI DIRECTLY FROM THE SPUTUM AND FECESJournal of Experimental Medicine, 1915